Press release
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Assessment, 2023 | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Key Companies - Takeda/Arrowhead Pharmaceuticals (faz
"Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Analysis
The report provides insights into:
- The report provides detailed insights into the key companies that are developing therapies in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Market.
- The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease treatment.
- It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
- It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
- Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage products (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Emerging Therapies Mechanism of Action Type -
- RNA interference
- Alpha 1 antitrypsin modulators
- Alpha 1 antitrypsin inhibitors
- Leucocyte elastase inhibitors
- Gene transference
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Latest Clinical, Commercial, and Regulatory Developments in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market
- On January 09, 2023, Takeda (TSE:4502/NYSE:TAK) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced topline results from the Phase 2 SEQUOIA clinical study of investigational fazirsiran (TAK-999/ARO-AAT) for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD-LD).
- In July 2021, Arrowhead Pharmaceuticals announced that it was granted Breakthrough Therapy designation (BTD) by the US FDA for ARO-AAT, also known as TAK-999, being co-developed with Takeda Pharmaceutical Company as a treatment for the rare genetic liver disease associated with alpha-1 antitrypsin deficiency (AATD).
- In July 2021, Dicerna Pharmaceuticals announced interim results from the four completed active-treatment dose cohorts (0.1, 1.0, 3.0, and 6.0 mg/kg) of its Phase I double-blind, placebo-controlled, randomized trial of belcesiran, an investigational GalXC™ RNAi therapeutic in development for the treatment of alpha-1 antitrypsin deficiency-associated liver disease (AATLD).
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Analysis
There are approx. 8+ key companies which are developing the therapies for Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease. Currently, Arrowhead Pharmaceuticals is leading the therapeutics market with its Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease drug candidates in the most advanced stage of clinical development.
The Leading Companies in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market Include:
- Centessa Pharmaceuticals
- Dicerna Pharmaceuticals
- PH Pharmaceuticals
- Arrowhead Pharmaceuticals
- Alnylam Pharmaceuticals
- LogicBio Therapeutics
- WaVe life Sciences
- Wuhan Healthgen Biotechnology
- Apic Bio
And Many Others
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Drugs Covered in the Report Include:
- ARO-AAT: Arrowhead Pharmaceuticals
- ZF874: Centessa Pharmaceuticals
- APB-101: Apic Bio
- Belcesiran: Dicerna Pharmaceuticals
- LIQ861: Liquidia Technologies
- Sotatercept: Acceleron Pharma
And Many More
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Current Treatment Patterns
4. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Late-Stage Products (Phase-III)
7. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Discontinued Products
13. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Product Profiles
14. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Key Companies
15. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Key Products
16. Dormant and Discontinued Products
17. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Unmet Needs
18. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Future Perspectives
19. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Trending Market Research Reports 2032 | DelveInsight
Technical Due Diligence Firms- https://www.delveinsight.com/consulting/due-diligence-services
Vital Sign Monitors Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Anastomosis Device Market- https://www.delveinsight.com/report-store/anastomotic-leak-devices-market
Asperger Syndrome Market- https://www.delveinsight.com/report-store/asperger-syndrome-market
B-Cell Maturation Antigen Targeted Therapies Market- https://www.delveinsight.com/report-store/b-cell-maturation-antigen-targeted-therapies-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Oncolytic Virus Cancer Therapy Pipeline- https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Shingles Market- https://www.delveinsight.com/report-store/shingles-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Assessment, 2023 | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Key Companies - Takeda/Arrowhead Pharmaceuticals (faz here
News-ID: 2897468 • Views: …
More Releases from DelveInsight Business Research
Renal Cancer Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies …
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Diffuse Intrinsic Pontine Glioma Pipeline Assessment 2024: Clinical Trials, FDA …
(Albany, USA) DelveInsight's, "Diffuse Intrinsic Pontine Glioma Pipeline Insight" report provides comprehensive insights about 25+ Diffuse Intrinsic Pontine Glioma companies and 25+ pipeline drugs in the Diffuse Intrinsic Pontine Glioma pipeline landscape. It covers the Diffuse Intrinsic Pontine Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diffuse Intrinsic Pontine Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further…
Ewing Sarcoma Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapie …
(Albany, USA) DelveInsight's, "Ewing Sarcoma Pipeline Insights" report provides comprehensive insights about 25+ Ewing Sarcoma companies and 25+ pipeline drugs in the Ewing Sarcoma pipeline landscape. It covers the Ewing Sarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ewing Sarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Acute Lymphocytic Leukemia Pipeline Assessment 2024: Clinical Trials, FDA Approv …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape. It covers the Acute Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acute Lymphocytic Leukemia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
More Releases for Alpha
Alpha Heater Reviews: Does Alpha Heater Really Work?
Alpha heater reviews
The winter can be a tough time when it comes to one’s pocket in the sense that most people spend a lot on money on electricity bill due to the increased cost of heating and electricity.
The winter is a season we all need to be prepared. It really require a careful and adequate arrangement to make sure everything is in order before its coming.
As the winter…
Alpha Heater in Canada: Black Friday Alpha Heater Amazon Deals
Get Alpha Heater For The Most Discounted Price >> https://rebrand.ly/AlphaHeaterCA
As temperature levels remain to fall across the USA and also Canada, The Alpha Heater could be an useful home appliance, one that heats up things up effectively and also swiftly. Utilizing this device, you can bring heat into any space of your home in an efficient fashion. Plus, the dropping temperature levels, together with work-at-home norms as well as the…
Alpha Heater Canada Review: Where to Buy Alpha Heater in Canada
Winter heat is a popular option with personal heaters. The Alpha Heater can be used by individuals to heat their homes or take them to work. Alpha Heater’s new design allows for 30% reductions in monthly electric bills compared to traditional heaters.
Did you know that traditional heaters can consume up to 1,500 watts an hour? Others use slightly higher or lower amounts. Imagine how your electricity bill looks after a…
Alpha Heater Review 2021: Shocking Facts about Alpha portable heater Reviews
Soonest, snow will be piling up on just about every doorstep around the country and you’ll be considering all options to stay warm during the winter. Don't be afraid Alpha heater Review is here to guide you through.
Whether you’re a naturally cold person or want to save some money space heaters may be the answer to all your cold-weather issues.
One easy way to get the job done? Alpha portable…
Alpha Xtra Boost Reviews - Where to Buy Alpha Xtra Boost Pills Online?
Alpha Xtra Boost Review: As men age, their capacity to act in bed deteriorates. Numerous men find that they are unable to satisfy their accomplice in a similar fashion as they did previously. This can initiate a never-ending rify in a relationship. In their edginess, a few men consider the guidance of supplements that may induce serious side-effects. Nonetheless, these are far distant from the correct decision. Alpha Xtra Boost…
Alpha Xtra Boost Reviews - Does Alpha Xtra Boost Really Work?
Reduced testosterone among men is a growing concern. However, while many consider taking the aid of chemicals for this purpose, it is instead recommended to go for dietary formulas instead. Alpha Xtra Boost is one such natural supplement that provides users with a number of ways to boost their performance in bed.
Get Alpha Xtra Boost Today >> https://rebrand.ly/o0aijnb
What is Alpha Xtra Boost?
This is a new dietary supplement that focuses…
